Repositioning Drugs for a Better Outcome®

Leading the treatment paradigm in patients suffering from refractive errors
Offering differentiated hospital products that improve efficacy, enhance safety and reduce healthcare costs
Leading the treatment paradigm in patients suffering from refractive errors
Offering differentiated hospital products that improve efficacy, enhance safety and reduce healthcare costs
Creating and nurturing a culture where employees find and pursue their professional purpose and passion
Offering differentiated hospital products that improve efficacy, enhance safety and reduce healthcare costs
Creating and nurturing a culture where employees find and pursue their professional purpose and passion
Repositioning Drugs for a Better Outcome®
Creating and nurturing a culture where employees find and pursue their professional purpose and passion
Repositioning Drugs for a Better Outcome®

Ophthalmics is a large and growing market. The total global cost of correcting refractive errors alone is estimated to be $2.8 trillion US, which to date no one has addressed with Pharmacological Interventions.

See what Nevakar has in development

Hospital Injectables is estimated to be a $624.5 billion market where suboptimal products, medication delays and compounding are serious challenges for hospitals everywhere.

See how Nevakar is addressing the challenges